Literature DB >> 25831441

No quiet surrender: molecular guardians in multiple sclerosis brain.

Lawrence Steinman.   

Abstract

The brain under immunological attack does not surrender quietly. Investigation of brain lesions in multiple sclerosis (MS) reveals a coordinated molecular response involving various proteins and small molecules ranging from heat shock proteins to small lipids, neurotransmitters, and even gases, which provide protection and foster repair. Reduction of inflammation serves as a necessary prerequisite for effective recovery and regeneration. Remarkably, many lesion-resident molecules activate pathways leading to both suppression of inflammation and promotion of repair mechanisms. These guardian molecules and their corresponding physiologic pathways could potentially be exploited to silence inflammation and repair the injured and degenerating brain and spinal cord in both relapsing-remitting and progressive forms of MS and may be beneficial in other neurologic and psychiatric conditions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25831441      PMCID: PMC4396493          DOI: 10.1172/JCI74255

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  96 in total

1.  Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation.

Authors:  Angelo A Chora; Paulo Fontoura; Andreia Cunha; Teresa F Pais; Sílvia Cardoso; Peggy P Ho; Lowen Y Lee; Raymond A Sobel; Lawrence Steinman; Miguel P Soares
Journal:  J Clin Invest       Date:  2007-01-25       Impact factor: 14.808

2.  Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.

Authors:  Maria Borrell-Pagès; Josep M Canals; Fabrice P Cordelières; J Alex Parker; José R Pineda; Ghislaine Grange; Elzbieta A Bryson; Martine Guillermier; Etienne Hirsch; Philippe Hantraye; Michael E Cheetham; Christian Néri; Jordi Alberch; Emmanuel Brouillet; Frédéric Saudou; Sandrine Humbert
Journal:  J Clin Invest       Date:  2006-04-06       Impact factor: 14.808

Review 3.  A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage.

Authors:  Lawrence Steinman
Journal:  Nat Med       Date:  2007-02       Impact factor: 53.440

4.  Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells.

Authors:  Denise C Fitzgerald; Guang-Xian Zhang; Mohamed El-Behi; Zoë Fonseca-Kelly; Hongmei Li; Shuo Yu; Christiaan J M Saris; Bruno Gran; Bogoljub Ciric; Abdolmohamad Rostami
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

5.  Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria.

Authors:  Ana Pamplona; Ana Ferreira; József Balla; Viktória Jeney; György Balla; Sabrina Epiphanio; Angelo Chora; Cristina D Rodrigues; Isabel Pombo Gregoire; Margarida Cunha-Rodrigues; Silvia Portugal; Miguel P Soares; Maria M Mota
Journal:  Nat Med       Date:  2007-05-13       Impact factor: 53.440

6.  Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.

Authors:  Richard A Rudick; William H Stuart; Peter A Calabresi; Christian Confavreux; Steven L Galetta; Ernst-Wilhelm Radue; Fred D Lublin; Bianca Weinstock-Guttman; Daniel R Wynn; Frances Lynn; Michael A Panzara; Alfred W Sandrock
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

7.  Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor.

Authors:  Robert Zivadinov; Bianca Weinstock-Guttman; Ralph Benedict; Miriam Tamaño-Blanco; Sara Hussein; Nadir Abdelrahman; Jackie Durfee; Murali Ramanathan
Journal:  Hum Mol Genet       Date:  2007-07-26       Impact factor: 6.150

8.  Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity.

Authors:  Shannon E Dunn; Shalina S Ousman; Raymond A Sobel; Luis Zuniga; Sergio E Baranzini; Sawsan Youssef; Andrea Crowell; John Loh; Jorge Oksenberg; Lawrence Steinman
Journal:  J Exp Med       Date:  2007-01-29       Impact factor: 14.307

9.  Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination.

Authors:  Shalina S Ousman; Beren H Tomooka; Johannes M van Noort; Eric F Wawrousek; Kevin C O'Connor; David A Hafler; Raymond A Sobel; William H Robinson; Lawrence Steinman
Journal:  Nature       Date:  2007-06-13       Impact factor: 49.962

10.  A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.

Authors:  Chris H Polman; Paul W O'Connor; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; David H Miller; J Theodore Phillips; Fred D Lublin; Gavin Giovannoni; Andrzej Wajgt; Martin Toal; Frances Lynn; Michael A Panzara; Alfred W Sandrock
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

View more
  11 in total

1.  Transcriptome Sequencing Identifies Potential Biomarker for White Matter Lesions Diagnosis in the Hypertension Population.

Authors:  Wendi Wang; Pei Sun; Fengyue Han; Chunjuan Wang; Yongxiang Wang; Xiang Wang; Lin Cong; Chuanqiang Qu
Journal:  Neurochem Res       Date:  2021-05-26       Impact factor: 3.996

2.  Parsing Physiological Functions of Erythropoietin One Domain at a Time.

Authors:  Lawrence Steinman
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

3.  Glu-tubulin is a marker for Schwann cells and can distinguish between schwannomas and neurofibromas.

Authors:  Josune García-Sanmartín; Susana Rubio-Mediavilla; José J Sola-Gallego; Alfredo Martínez
Journal:  Histochem Cell Biol       Date:  2016-06-09       Impact factor: 4.304

4.  A Journey in Science: The Privilege of Exploring the Brain and the Immune System.

Authors:  Lawrence Steinman
Journal:  Mol Med       Date:  2016-06-02       Impact factor: 6.354

5.  Researchers Expand Focus on Progressive Forms Of Multiple Sclerosis: Efforts to Pinpoint the Beginning of Disease May Yield Clues to Treatment.

Authors:  Susan Worley
Journal:  P T       Date:  2015-09

6.  Maresin 1 Promotes Inflammatory Resolution, Neuroprotection, and Functional Neurological Recovery After Spinal Cord Injury.

Authors:  Isaac Francos-Quijorna; Eva Santos-Nogueira; Karsten Gronert; Aaron B Sullivan; Marcel A Kopp; Benedikt Brommer; Samuel David; Jan M Schwab; Ruben López-Vales
Journal:  J Neurosci       Date:  2017-11-06       Impact factor: 6.167

7.  CYBB/NOX2 in conventional DCs controls T cell encephalitogenicity during neuroinflammation.

Authors:  Christian W Keller; Monika B Kotur; Sarah Mundt; Nikolaos Dokalis; Laure-Anne Ligeon; Ajay M Shah; Marco Prinz; Burkhard Becher; Christian Münz; Jan D Lünemann
Journal:  Autophagy       Date:  2020-05-13       Impact factor: 16.016

Review 8.  Harnessing the integrated stress response for the treatment of multiple sclerosis.

Authors:  Sharon W Way; Brian Popko
Journal:  Lancet Neurol       Date:  2016-02-10       Impact factor: 44.182

9.  Expression of the Antioxidative Enzyme Peroxiredoxin 2 in Multiple Sclerosis Lesions in Relation to Inflammation.

Authors:  David Voigt; Uta Scheidt; Tobias Derfuss; Wolfgang Brück; Andreas Junker
Journal:  Int J Mol Sci       Date:  2017-04-04       Impact factor: 5.923

10.  Distinctive sphingolipid patterns in chronic multiple sclerosis lesions.

Authors:  Maria Podbielska; Zdzislaw M Szulc; Toshio Ariga; Anna Pokryszko-Dragan; Wojciech Fortuna; Małgorzata Bilinska; Ryszard Podemski; Ewa Jaskiewicz; Ewa Kurowska; Robert K Yu; Edward L Hogan
Journal:  J Lipid Res       Date:  2020-08-07       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.